Evaluation of the effect of dapagliflozi
✍
Glenn F. Carlson; Conrad K. P. Tou; Shamik Parikh; Bruce K. Birmingham; Kathleen
📂
Article
📅
2011
🏛
Springer-Verlag
🌐
English
⚖ 362 KB
## Introduction Dapagliflozin is a first-in-class sodium-glucose transporter 2 (SGLT2) inhibitor under investigation for the treatment of type 2 diabetes mellitus. A thorough QTc study was conducted, according to International Conference on Harmonization E14 guidelines, to characterize the effect o